Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Sanitization of Isolators in Sterile Manufacturing – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Sanitization of Isolators in Sterile Manufacturing – V 2.0

Standard Operating Procedure for Sanitization of Isolators in Sterile Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/155/2025
Supersedes SOP/SIM/155/2022
Page No. Page 1 of 14
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

To define the procedure for sanitization of isolators used in sterile injectable manufacturing. This SOP ensures consistent and effective decontamination practices, preventing microbial contamination and maintaining aseptic processing environments in compliance with cGMP and regulatory standards.

2. Scope

This SOP applies

to all isolators used in sterile areas of the facility for aseptic manufacturing operations, including those used in filling lines, compounding operations, and sampling procedures.

3. Responsibilities

  • Production Operator: Carries out the sanitization as per the SOP.
  • Engineering: Ensures proper functioning of isolator systems and environmental controls.
  • QA Officer: Monitors compliance with procedure and approves sanitization records.

4. Accountability

The Head of Production and Head of QA are accountable for the proper execution and verification of isolator sanitization activities.

See also  Sterile Injectable Manufacturing: SOP for Evaluating Injection Viscosity and Compatibility - V 2.0

5. Procedure

5.1 Preparation for Sanitization

  1. Ensure isolator is shut down and power to glove ports and internal fans is turned off.
  2. Verify isolator chamber is empty and free from manufacturing components or product remnants.
  3. Check the availability of sanitizing agents, cleaning tools, and personal protective equipment (PPE).
  4. Wear approved sterile PPE before entering the Grade B/C area where the isolator is located.

5.2 Cleaning Before Sanitization

  1. Using a sterile lint-free cloth soaked in Water for Injection (WFI), clean all internal isolator surfaces including walls, glass, and stainless steel surfaces.
  2. Remove residues, visible particles, and any dried product using a non-abrasive motion.
  3. Change the cloth when visibly dirty or after each major surface to avoid cross-contamination.
  4. Allow to dry or wipe with a dry sterile cloth if required.

5.3 Sanitization with Disinfectants

  1. Use an approved sporicidal disinfectant (e.g., Hydrogen Peroxide, Peracetic Acid) as per the disinfectant rotation policy.
  2. Spray or fog the disinfectant using validated equipment designed for isolators or vaporized hydrogen peroxide (VHP) systems.
  3. Ensure full coverage including glove ports, viewing window interiors, air intake filters, and floor plates.
  4. Maintain the required contact time (e.g., 30 minutes) as specified in the MSDS/SOP for the disinfectant.
  5. Ventilate the isolator post-fumigation if required and ensure all vapors are neutralized.
See also  Sterile Injection Manufacturing: SOP for Use of Automated Labeling Machines in Packing Lines - V 2.0

5.4 Post-Sanitization Checks

  1. Visually inspect all internal areas of the isolator to ensure no chemical residues remain.
  2. Perform swab tests at predefined locations (Annexure-1) for microbial monitoring post-sanitization.
  3. Record results in the Isolator Sanitization Log (Annexure-2).
  4. Label the isolator with “SANITIZED” status tag along with date/time and initials of the operator and QA reviewer.

5.5 Frequency

  • Routine sanitization: Before start of each aseptic operation batch.
  • In case of product changeover, or observed contamination or as per validated frequency.

5.6 Safety Precautions

  1. Refer to the Safety Data Sheet (SDS) of the disinfectant before use.
  2. Ensure isolator chamber is sealed before fumigation or fogging starts.
  3. Never reuse disinfectant solutions beyond their validated hold time.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • PPE: Personal Protective Equipment
  • QA: Quality Assurance
  • WFI: Water for Injection
  • MSDS: Material Safety Data Sheet
  • VHP: Vaporized Hydrogen Peroxide
See also  Sterile Injectable Manufacturing: SOP for Cross-Contamination Prevention during Dispensing - V 2.0

7. Documents

  1. Annexure-1: Isolator Microbial Monitoring Locations
  2. Annexure-2: Isolator Sanitization Log
  3. Annexure-3: Disinfectant Usage Record

8. References

  • EU GMP Annex 1: Manufacture of Sterile Medicinal Products
  • USP <797>: Pharmaceutical Compounding — Sterile Preparations
  • 21 CFR Part 211

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Isolator Microbial Monitoring Locations

Location Swab ID Result (cfu) Limit Status
Left Wall SWB-01 0 ≤1 Pass
Glove Port 1 SWB-02 0 ≤1 Pass

Annexure-2: Isolator Sanitization Log

Date Isolator ID Disinfectant Used Operator QA Reviewer
23/06/2025 ISO-01 Hydrogen Peroxide Ravi Kumar Meena Gupta

Annexure-3: Disinfectant Usage Record

Batch No. Preparation Date Expiry Used For Prepared By
HP202506 22/06/2025 23/06/2025 ISO-01 Sunil Mehta

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial version New SOP Head QA
24/06/2025 2.0 Included VHP method and updated disinfection policy Annual Review Head QA
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Biosimilars: SOP for Viral Filtration Using 20 nm Filters – V 2.0
Next Post: Audit Risk: Logbooks Reflect Actions Not Found in SOPs

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version